On preferential basis
Sequent Scientific announced that the Board of Directors of the Company on 13 August 2015 has approved the allotment of 757,734 equity shares at a price of Rs. 669.10 per equity share (including a premium of Rs. 659.10 per equity share) to Devicam Capital LLP, a promoter group entity by way of preferential issue in compliance with Chapter VII of the Securities & Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009.Consequent to the allotment, the paid up equity share capital of the Company has increased from Rs. 412,618,260/- consisting of 41,261,826 equity shares of Rs. 10/- each to Rs. 420,195,600/- consisting of 42,019,560 equity shares of Rs. 10/- each.
Powered by Capital Market - Live News